National Institute of Allergy and Infectious Diseases Seeks Licensees and CRADA Collaborators for Influenza A PB2 Gene Technology

Summary

The National Institutes of Health is seeking partners to jointly develop and commercialize its influenza A PB2 gene technology, which could have important clinical and research applications.